. Levi's fiscal-third quarter revenue missed expectations, but earnings per share came in slightly above. Levi's CEO said consumers were buying fewer items due to inflation and rising mortgage and gas prices.— The Dutch health tech company dropped more than 8.7% after the U.S. Food and Drug Administration said its handling of its 2021 sleep apnea device recallof some Model 3 and Model Y vehicles in the U.S.
The move followed the company's third-quarter vehicle production and deliveries update, which missed analysts' expectations.— Shares of the biopharmaceutical company rose 5.5% after Apellis reported growing sales for its Syfovre drug in August. JPMorgan upgraded the stock to overweight from neutral, saying that the success of Syfovre should shift sentiment around Apellis heading into 2024.
Россия Последние новости, Россия Последние новости
Similar News:Вы также можете прочитать подобные новости, которые мы собрали из других источников новостей
Источник: MarketWatch - 🏆 3. / 97 Прочитайте больше »
Источник: MarketWatch - 🏆 3. / 97 Прочитайте больше »
Источник: MarketWatch - 🏆 3. / 97 Прочитайте больше »